A detailed history of Nfj Investment Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Nfj Investment Group, LLC holds 96,847 shares of PCRX stock, worth $1.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
96,847
Previous 102,882 5.87%
Holding current value
$1.5 Million
Previous $3.01 Million 7.85%
% of portfolio
0.09%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.5 - $31.51 $153,892 - $190,162
-6,035 Reduced 5.87%
96,847 $2.77 Million
Q1 2024

May 15, 2024

SELL
$27.7 - $35.48 $375,916 - $481,499
-13,571 Reduced 11.65%
102,882 $3.01 Million
Q4 2023

Feb 15, 2024

BUY
$26.32 - $34.31 $88,935 - $115,933
3,379 Added 2.99%
116,453 $3.93 Million
Q3 2023

Nov 08, 2023

BUY
$30.68 - $40.09 $3.47 Million - $4.53 Million
113,074 New
113,074 $3.47 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $712M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Nfj Investment Group, LLC Portfolio

Follow Nfj Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nfj Investment Group, LLC with notifications on news.